At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declining public trust in science?

September 25, 2026

Vol.52 No.35

By Claire Marie Porter and Paul Goldberg

News Analysis Regulatory News

FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says

The FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted in favor of Galleri to become the first multi-cancer detection test to receive regulatory approval.

September 25, 2026

Vol.52 No.35

By Jacquelyn Cobb and Sara Willa Ernst

Perspective

When did stage 3B lung cancer become “early stage”?

My recent column about Merck’s television commercial for perioperative Keytruda left me with a question I could not shake.

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.

September 25, 2026

Vol.52 No.35

By Claire Marie Porter

In Brief

Rutika Mehta named director of upper GI medical oncology at NYU

Rutika Mehta has joined NYU Langone Health’s Perlmutter Cancer Center as director of upper GI medical oncology.

September 25, 2026

Vol.52 No.35

In Brief

Colorectal Cancer Alliance appoints four new board members

The Colorectal Cancer Alliance has announced the appointment of four members to its board of directors.

September 25, 2026

Vol.52 No.35

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

YOU MAY BE INTERESTED IN

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says

When did stage 3B lung cancer become “early stage”?

HHS issues direct final rule to reduce reliance on animal testing

Rutika Mehta named director of upper GI medical oncology at NYU

Colorectal Cancer Alliance appoints four new board members

Renew today!

Subscriber content

Never miss an issue!

Login

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

YOU MAY BE INTERESTED IN

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want itLucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claimsClinical benefit will not be considered for approval, FDA says

When did stage 3B lung cancer become “early stage”?

HHS issues direct final rule to reduce reliance on animal testing

Rutika Mehta named director of upper GI medical oncology at NYU

Colorectal Cancer Alliance appoints four new board members

Never miss an issue!

Login

The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish

FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says